Stay updated on Ixazomib Combo in Relapsed/Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.

Latest updates to the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page
- Check5 days agoChange DetectedThe latest version returned on 2026-06-24 adds sections such as Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Document Section, Arms and Interventions, and Study Design to the history, and notes that Quality Control Review Has Not Concluded. This reflects expanded documentation in the study record and a current QC status for ongoing review.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe study record history now displays that recruitment has closed and adds a new version tag, Revision: v3.6.0, while removing the previous Revision: v3.5.5.SummaryDifference0.4%

- Check26 days agoChange DetectedStudy Record Versions now show 'Results Submitted' with Revision: v3.5.5, replacing 'No Results Posted' and Revision: v3.5.4. This situates the study within the record's results-availability timeline and documents the latest revision in the history.SummaryDifference0.2%

- Check48 days agoChange DetectedA new page revision entry v3.5.4 has been added, and the previous entry v3.5.3 has been removed, updating the page's displayed version in the footer.SummaryDifference0.1%

- Check70 days agoChange DetectedThis update only changes the site’s displayed revision/version indicator from v3.5.0 to v3.5.3, with no indication of changes to the clinical trial’s history or study details.SummaryDifference0.1%

- Check105 days agoChange DetectedA new revision entry, v3.5.0, was added to the history and revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Ixazomib Combo in Relapsed/Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.